The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
MediWound has submitted a BLA to the FDA seeking the approval of NexoBrid for eschar removal in adults with deep partial-thickness and/or full-...
read more
American Pharmaceutical Review has launched a new information resource to cover the development and manufacturing of the highest quality ...
read more
Novartis announced the EC has approved Enerzair® Breezhaler as a maintenance treatment of asthma in adult patients not adequately controlled with a ...
read more
Palatin announced reinitiation of enrollment of its Phase 2 study with PL9643 for the treatment of dry eye disease.
read more
INTERPHEX, American Pharmaceutical Review, and Pharmaceutical Outsourcing have announced the winners of the 2020 INTERPHEX Exhibitor Awards.
read more
OWP has submitted for U.S. patent protection for powder for oral liquid formulation of duloxetine hydrochloride.
read more
CEBINA GmbH has announced positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with ...
read more
Heron announced the initiation of a Phase 2 clinical study evaluating CINVANTI injectable emulsion in early hospitalized patients with COVID-19.
read more
To reduce the risk of death from opioid overdose, the FDA is making the following recommendations about the opioid reversal medicine, naloxone.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Averitas Pharma has received FDA approval for QUTENZA 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of...
read more
AbbVie announced upadacitinib plus topical corticosteroids met the co-primary endpoints and all secondary endpoints in AD Up, the third pivotal Phase ...
read more
GlaxoSmithKline Pharmaceuticals
GSK has started shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2020-21 flu season.
read more
Wednesday, August 05, 2020
AbbVie announced the Phase 3 trial evaluating atogepant met its primary endpoint of statistically significantly greater reduction in mean monthly ...
read more
Thursday, August 06, 2020
BioAegis Therapeutics enrolled its first patient in its Phase 2 study of hospitalized patients with severe COVID-19 pneumonia.
read more